نتائج البحث

Cost-effectiveness acceptability curves that compare the cost-effectiveness of SOC and (a) FIF, (b) Hybrid, (c) IMRT, (d) STD-VMAT, (e) NC-VMAT and (f) MA-VMAT at different willingness to pay (WTP) thresholds.

• Authors : Yibo Xie (9200617); Beibei Guo (1395388); Rui Zhang (13940)

Subjects: Medicine; Developmental Biology; Cancer

تفاصيل العنوان

基于两种模型的帕博利珠单抗联合化疗一线 治疗晚期胆道癌的经济学评价.

• Authors : 向贵圆¹ ; 刘　柳²; 黄月月³

• Source: Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi. 2024, Vol. 24 Issue 9, p1113-1122. 6p.

تفاصيل العنوان

Congenital Heart Disease in Adults: a cost- effectiveness analysis of Public Policies and Interventions

• Authors : Barradas Pereira Martins Pires, Ana Filipa;

Subjects: Congènites; Congenital; Congénitas616.1

• Source: TDX (Tesis Doctorals en Xarxa)

تفاصيل العنوان

Cost-utility analysis of omalizumab for the treatment of chronic spontaneous urticaria in China.

• Authors : Huang, Yueyang¹ (AUTHOR) ; Yuan, Hongmei¹ (AUTHOR) ; Huang, Zhe¹ (AUTHOR)

• Source: Cost Effectiveness & Resource Allocation. 7/22/2025, Vol. 23 Issue 1, p1-10. 10p.

تفاصيل العنوان

The Carbon Reduction Contribution of Battery Electric Vehicles: Evidence from China.

• Authors : Sun, Ying^1,2 (AUTHOR); Xiong, Le^1,2 (AUTHOR); Yan, Rui^1,2 (AUTHOR)

• Source: Energies (19961073). Jul2025, Vol. 18 Issue 13, p3578. 32p.

تفاصيل العنوان

Cost-effectiveness of total knee arthroplasty, unicompartmental knee arthroplasty, and high tibial osteotomy for medial compartment knee osteoarthritis in young patients: a Canadian public payer perspective.

• Authors : Ruangsomboon, Pakpoom^1,2; Ruangsomboon, Onlak^3,4,5 ; Tam, Davis²

• Source: Journal of Orthopaedic Surgery & Research. 5/31/2025, Vol. 20 Issue 1, p1-12. 12p.

تفاصيل العنوان

Trastuzumab deruxtecan versus trastuzumab emtansine for human epidermal growth factor receptor 2 positive metastatic breast cancer: cost-effectiveness analysis from Iranian experience.

• Authors : Yaghoubi, Neda¹ (AUTHOR); Fatemi, Behzad² (AUTHOR); Ahmadi, Razieh¹ (AUTHOR)

• Source: BMC Health Services Research. 5/17/2025, Vol. 25 Issue 1, p1-8. 8p.

تفاصيل العنوان

Cost-effectiveness of CDK4/6 inhibitors for second-line HR+/HER2− advanced or metastatic breast cancer in China.

• Authors : Jia, Caifeng¹ (AUTHOR); Zhang, Sen² (AUTHOR); Wang, Jie³ (AUTHOR)

• Source: Scientific Reports. 4/14/2025, Vol. 15 Issue 1, p1-13. 13p.

تفاصيل العنوان

Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China.

• Authors : Liu, Shixian^1,2,3 (AUTHOR); Wang, Kaixuan⁴ (AUTHOR); Chen, Hao^1,2,3 (AUTHOR)

• Source: Cost Effectiveness & Resource Allocation. 3/19/2025, Vol. 23 Issue 1, p1-8. 8p.

تفاصيل العنوان

Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting.

• Authors : Siegfrids, Filip (AUTHOR); Heinävaara, Sirpa (AUTHOR); Sarkeala, Tytti (AUTHOR)

Subjects: Medical screening; Medical sciences; Public healthFinland

• Source: Health Economics Review. 4/11/2025, Vol. 15 Issue 1, p1-13. 13p.

تفاصيل العنوان